نتایج جستجو برای: and arb

تعداد نتایج: 16827451  

Journal: :Current medicinal chemistry 2008
Y S Boriskin I A Leneva E-I Pécheur S J Polyak

Arbidol (ARB; ethyl-6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-indole-3-carboxylate hydrochloride monohydrate), is a Russian-made potent broad-spectrum antiviral with demonstrated activity against a number of enveloped and non-enveloped viruses. ARB is well known in Russia and China, although to a lesser extent in western countries. Unlike other broad-spectrum a...

Journal: :Oncology 2012
Seung Tae Kim Kyong Hwa Park Sang Cheul Oh Jae Hong Seo Jun Suk Kim Sang Won Shin Yeul Hong Kim

BACKGROUND The renin-angiotensin system (RAS) is related to the regulation of cell proliferation, angiogenesis, and tumor progression. PATIENTS AND METHODS We retrospectively analyzed the effect of angiotensin I-converting enzyme inhibitors (ACEIs) and angiotensin II type-1 receptor blockers (ARBs) in 63 patients with advanced gastric cancer (AGC) with platinum-based chemotherapy. All patient...

2011
Ho Jun Chin Se Won Oh Ho Suk Goo Jieun Oh Jung Woo Noh Jong Tae Cho Ki Young Na Suhnggwon Kim Dong-Wan Chae

Angiotensin II type 1 receptor blocker (ARB), which is frequently prescribed in patients with glomerulonephritis (GN), is suggested to increase the risk of cancer. We registered 3,288 patients with renal biopsy and analyzed the relationship between the use of renin-angiotensin-aldosterone system (RAAS) blockade and the incidence of cancer or cancer mortality. After renal biopsy, cancer develope...

Journal: :Journal of the American College of Cardiology 2016
Marie Evans Juan-Jesus Carrero Karolina Szummer Axel Åkerblom Robert Edfors Jonas Spaak Stefan H Jacobson Pontus Andell Lars Lindhagen Tomas Jernberg

BACKGROUND There is no consensus whether angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) should be used for secondary prevention in all or in only high-risk patients after an acute myocardial infarction (AMI). OBJECTIVES This study sought to investigate whether ACEI/ARB treatment after AMI is associated with better outcomes across different risk profiles,...

Journal: :Acta medica Okayama 2012
Yoshihisa Hanayama Haruhito Adam Uchida Yoshio Nakamura Hirofumi Makino

Angiotensin receptor blockers (ARBs) are the first-line antihypertensive agents. In clinical practice, it is often difficult to achieve the recommended blood pressure level by ARBs in their ordinal dosages alone. This study examined the practical efficacy of a combination therapy of ARB with thiazide diuretics for lowering morning home blood pressure (MHBP) in comparison to high-dose ARB therap...

2016
Yun-Tao Zhao Peng-Yang Li Jian-Qiang Zhang Lei Wang Zhong Yi

Angiotensin II receptor blockers (ARB) are widely used drugs that are proven to reduce cardiovascular disease events; however, several recent meta-analyses yielded conflicting conclusions regarding the relationship between ARB and cancer incidence, especially when ARB are combined with angiotensin-converting enzyme inhibitors (ACEI).We investigated the risk of cancer associated with ARB at diff...

2015
Cho-Kai Wu Yao-Hsu Yang Jyh-Ming Jimmy Juang Yi-Chih Wang Chia-Ti Tsai Ling-Ping Lai Juey-Jen Hwang Fu-Tien Chiang Pau-Chung Chen Jiunn-Lee Lin Lian-Yu Lin Hsueh hwa Wang.

Long-term benefit of using a renin-angiotensin-aldosterone system blocker such as an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin II receptor blocker (ARB) for patients already receiving dialysis remains undetermined. The aim of this study is to assess the efficacy and safety of ACEI or ARB use in dialysis patients. We performed a population-based cohort study with time-to-e...

2017
Nai-Fang Chang Yi-Shyan Chen Ying-Ju Lin Ting-Hsuan Tai An-Ni Chen Chen-Hsuan Huang Chih-Chien Lin

Arbutin (Arb) and deoxyArbutin (dA) are both effective hypopigmentation agents. However, they are glucoside derivatives of hydroquinone (HQ), which may be decayed into HQ under higher energy environments. Therefore, safety and toxicity are very important issues when considering the usage of these compounds. However, no study has verified the properties of Ultra-Violet B (UVB)-irradiated Arb and...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006
Richard N Formica Amy L Friedman Marc I Lorber J Douglas Smith Tom Eisen Margaret J Bia

BACKGROUND Blockade of the renin-angiotensin-aldosterone system in the early post-transplant period remains controversial. Angiotensin II-receptor blockers (ARB) have many benefits to the patient with chronic kidney disease and these benefits may also apply to the renal transplant recipient (RTR). Additionally, there are theoretical benefits of ARB use in RTR. This study was designed to investi...

Journal: :archives of anesthesiology and critical care 0
mihan jafari javid tehran university of medical sciences ghazale khademian tehran university of medical sciences,

background: establishment of a patent airway and preserving spontaneous ventilation is a necessity in predicted difficult airway. airway regional blocks are commonly used in predicted difficult airway but the known limitations of these techniques propose the need to suggest alternative methods. this study compares subcutaneous dissociative conscious sedation (sdcs); a recently reported method o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید